J. Neumann

Enhanced Angiotensin II type 1 receptor expression in leukocytes of patients with chronic kidney disease.

J. Joles, B. Braam, P. Boer, 2011, European journal of pharmacology.

Pathogenesis and treatment of hypertension in polycystic kidney disease

P. Blankestijn, G. Ligtenberg, J. Neumann, 2002, Current opinion in nephrology and hypertension.

Sympathetic Hyperactivity in Hypertensive Chronic Kidney Disease Patients Is Reduced During Standard Treatment

P. Blankestijn, H. Koomans, P. Boer, 2007, Hypertension.

Sympathetic nerve activity is inappropriately increased in chronic renal disease.

P. Blankestijn, H. Koomans, P. Oey, 2003, Journal of the American Society of Nephrology : JASN.

Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.

M. Bots, P. Blankestijn, P. Oey, 2009, Journal of nephrology.

Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.

P. Blankestijn, H. Koomans, G. Ligtenberg, 2004, Journal of the American Society of Nephrology : JASN.

Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment.

P. Blankestijn, H. Koomans, G. Ligtenberg, 2004, Kidney international.